PCRX - Pacira BioSciences, Inc.
22.86
0 0%
Share volume: 931,883
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$22.86
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 07-30-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 08-05-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 167.117 M | 178.023 M | 168.573 M | 888.219 M | 168.923 M | 181.099 M | 179.516 M | 196.873 M | |
| Cost of revenue | 47.416 M | 44.262 M | 38.864 M | 39.886 M | 34.306 M | 40.866 M | 34.278 M | 40.299 M | |
| Gross profit | 119.701 M | 133.761 M | 129.709 M | 848.333 M | 134.617 M | 140.233 M | 145.238 M | 156.574 M | |
| 11.75% | -3.03% | 554.03% | -84.13% | 4.17% | 3.57% | 7.81% | |||
| Operating expenses | 90.264 M | 88.464 M | 93.437 M | 103.511 M | 112.118 M | 116.778 M | 117.763 M | 139.412 M | |
| Selling general and admin | 72.026 M | 68.126 M | 74.333 M | 79.614 M | 86.776 M | 88.578 M | 91.797 M | 101.608 M | |
| Research and development | 18.238 M | 20.338 M | 19.104 M | 23.897 M | 25.342 M | 28.200 M | 25.966 M | 37.804 M | |
| Total expenses | 152.002 M | 147.048 M | 269.236 M | 1.110 B | 132.627 M | 131.734 M | 138.876 M | 154.234 M | |
| -3.26% | 83.09% | 312.21% | -88.05% | -0.67% | 5.42% | 11.06% | |||
| Operating income | 15.115 M | 30.975 M | -139.527 M | 24.704 M | 1.990 M | 8.499 M | 6.362 M | 2.340 M | |
| Ebit | 15.115 M | 30.975 M | -139.649 M | 34.916 M | 6.391 M | -2.240 M | 6.252 M | 2.168 M | |
| Pretax income | 13.640 M | 36.584 M | -138.856 M | -37.580 M | 8.706 M | -1.927 M | 9.524 M | 571.000 K | |
| 168.21% | -479.55% | -72.94% | -123.17% | -122.13% | -594.24% | -94.00% | |||
| Income tax | 4.661 M | 17.698 M | 4.610 M | 45.939 M | 3.894 M | 2.920 M | 4.092 M | -1.066 M | |
| Net income basic | 8.979 M | 18.886 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 110.34% | -100.00% | ||||||||
| Net income | 8.979 M | 18.886 M | -143.466 M | -83.519 M | 4.812 M | -4.847 M | 5.432 M | 1.637 M | |
| 110.34% | -859.64% | 41.78% | 105.76% | -200.73% | 212.07% | -69.86% |